Vimarsana
Biggest News Aggregation in the World

Reliance Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reliance Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reliance Life Sciences Today - Breaking & Trending Today

Coronavirus updates | India records 42,618 Covid cases, 330 deaths in a day - Vimarsana News

Coronavirus updates | India records 42,618 Covid cases, 330 deaths in a day

With 42,618 people testing positive for coronavirus, India's total tally of COVID-19 cases rose to 3,29,45,907, while active cases touched 4,05,681. The death toll climbed to 4,40,225 with 330 fresh fatalities, according to the data updated at 8 a.m.In a span of 24 hours, the active caseload rose by 5,903. The number of active cases now comprise 1.23% of the total infections, while the

Global Biosimilar Monoclonal Antibodies Market Report 2024: Future Market Growth Powered by Biologics and Personalized Therapy Advances - Vimarsana News

Global Biosimilar Monoclonal Antibodies Market Report 2024: Future Market Growth Powered by Biologics and Personalized Therapy Advances

/PRNewswire/ -- The "Biosimilar Monoclonal Antibodies Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The expansion of the...

Biologic Therapeutic Drugs Market Analysis Reveals Robust - Vimarsana News

Biologic Therapeutic Drugs Market Analysis Reveals Robust

Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The

Global Biologic Therapeutic Drugs Market Report 2024 with Focus on Emerging Technology for Biologics Manufacturing - Vimarsana News

Global Biologic Therapeutic Drugs Market Report 2024 with Focus on Emerging Technology for Biologics Manufacturing

/PRNewswire/ -- The "Biologic Therapeutic Drugs: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The biologics...

Biosimilars Market is Projected to Reach an Estimate of $143.6 Billion by 2031, with CAGR of 24.7% : Allied Market Research - Vimarsana News

Biosimilars Market is Projected to Reach an Estimate of $143.6 Billion by 2031, with CAGR of 24.7% : Allied Market Research

The growth of the global biosimilars market is driven by the incidence of various types of cancers, including lung, blood, and brain tumors, which has increased significantly, and an increase in the incidence of autoimmune conditions such as ankylosing spondylitis and rheumatoid arthritis.Wilmington, Delaware, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Allied Market Research released a report, titled, “Biosimilars Market by Type (Erythropoietin, Human growth hormone, Monoclonal antibodies, Granulocyte-Co

Source: yahoo.com